Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Queensland Health
Moodys
Fish and Richardson
Express Scripts
Mallinckrodt

Generated: April 22, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR METHYLPREDNISOLONE ACETATE

« Back to Dashboard

Clinical Trials for Methylprednisolone Acetate

Trial ID Title Status Sponsor Phase Summary
NCT00290589 A Trial of Corticosteroids for Low Back Pain Completed Montefiore Medical Center Phase 3 Low back pain is a common symptom that functionally disables many people. When the low back pain is accompanied by pain that shoots down the leg, it is felt to be caused by a herniated disc. We are conducting this study to determine if a powerful anti-inflammatory agent will decrease the pain and functional impairment that is associated with this illness.
NCT00492973 Do Corticosteroid Injections During Total Knee Replacement Improve Early Clinical Results? Completed St. Joseph's Health Care London N/A Prior to surgery, a pharmacist will randomly assign participating patients to one of two groups. One group will get an injection in the knee during surgery that contains medications to limit pain and an antibiotic. A second group will get an injection in the knee during surgery that contains the same pain medications and antibiotic along with a corticosteroid to control inflammation. Corticosteroids are anti-inflammatory medications, not to be confused with muscle-building anabolic steroids you may have heard about in the news. Each patient will have an equal chance of being in either of the two groups. This study will test the safety and efficacy of methylprednisolone acetate in the treatment of pain and inflammation following total knee replacement.
NCT00492973 Do Corticosteroid Injections During Total Knee Replacement Improve Early Clinical Results? Completed New Lexington Clinic N/A Prior to surgery, a pharmacist will randomly assign participating patients to one of two groups. One group will get an injection in the knee during surgery that contains medications to limit pain and an antibiotic. A second group will get an injection in the knee during surgery that contains the same pain medications and antibiotic along with a corticosteroid to control inflammation. Corticosteroids are anti-inflammatory medications, not to be confused with muscle-building anabolic steroids you may have heard about in the news. Each patient will have an equal chance of being in either of the two groups. This study will test the safety and efficacy of methylprednisolone acetate in the treatment of pain and inflammation following total knee replacement.
NCT01037907 A Study of Orally Administered BGC20-0134 (Structured Lipid) in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) Terminated BTG International Inc. Phase 2 To determine the efficacy and safety of an oral drug (BGC20-0134) in patients with relapsing remitting multiple sclerosis. Specifically, the cumulative number of new gadolinium enhancing lesions after 24 weeks of treatment with BGC20-0134.
NCT01132677 A Study Comparing Viscosupplementation and Corticosteroid Injections for Knee Osteoarthritis Enrolling by invitation LifeMark Health N/A Do differences exist between patients who receive a single intra-articular injection of corticosteroid versus patients who receive a single intra-articular injection of hyaluronic acid for the treatment of knee osteoarthritis at 1, 3 and 6 weeks, and 3 and 6 months post injection?
NCT01144143 Treatment Of Knee Osteoarthritis With Intra-Articular Infliximab Completed Centocor, Inc. Phase 4 The purpose of this study is to determine if an anti-inflammatory drug, called infliximab, will reduce inflammation in the synovial lining in patients with an early stage of osteoarthritis of the knee. It will also help determine if the study medication decreases the accumulation of synovial fluid and prevents cartilage breakdown.
NCT01144143 Treatment Of Knee Osteoarthritis With Intra-Articular Infliximab Completed University of Kansas Phase 4 The purpose of this study is to determine if an anti-inflammatory drug, called infliximab, will reduce inflammation in the synovial lining in patients with an early stage of osteoarthritis of the knee. It will also help determine if the study medication decreases the accumulation of synovial fluid and prevents cartilage breakdown.
Trial ID Title Status Sponsor Phase Summary

Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Methylprednisolone Acetate

Condition Name

Condition Name for Methylprednisolone Acetate
Intervention Trials
Osteoarthritis, Knee 2
Osteoarthritis 1
Cervical Spondylotic Myelopathy 1
Prostate Cancer 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Methylprednisolone Acetate
Intervention Trials
Osteoarthritis 4
Multiple Sclerosis 3
Syndrome 3
Osteoarthritis, Knee 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Methylprednisolone Acetate

Trials by Country

Trials by Country for Methylprednisolone Acetate
Location Trials
United States 10
Egypt 2
Spain 2
Russian Federation 2
Belgium 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Methylprednisolone Acetate
Location Trials
Texas 2
Kansas 2
New York 2
Ohio 1
Nebraska 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Methylprednisolone Acetate

Clinical Trial Phase

Clinical Trial Phase for Methylprednisolone Acetate
Clinical Trial Phase Trials
Phase 4 5
Phase 3 3
Phase 2/Phase 3 1
[disabled in preview] 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Methylprednisolone Acetate
Clinical Trial Phase Trials
Recruiting 7
Completed 6
Enrolling by invitation 3
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Methylprednisolone Acetate

Sponsor Name

Sponsor Name for Methylprednisolone Acetate
Sponsor Trials
National Institute for Health Research, United Kingdom 2
Churchill Pharmaceutical LLC 2
Elliot Frohman 1
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Methylprednisolone Acetate
Sponsor Trials
Other 31
Industry 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Healthtrust
Fish and Richardson
Daiichi Sankyo
McKesson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.